Q2 2020

Filed Aug 6, 2020 · 10-Q · 37 days after period end · 0001564590-20-037777

Q2 2020 · 10-Q

Revenue

$379.00K

±0.0% vs Q2 2019

Net Income

-$17.06M

N/M vs Q2 2019

EPS Diluted

-$0.42

N/M vs Q2 2019

Operating Income-$16,610,000N/M

Operating Cash Flow

Same quarter

Metric	Q2 2020	Q2 2019	Q2 2018	Q2 2017
Revenue	$379.00K	$379.00K	$379.00K	$305.00K
Net Income	-$17.06M	-$14.92M	-$18.39M	-$13.64M
EPS Diluted	-$0.42	-$0.47	$0.74	-$0.47

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Syndax Pharmaceuticals Inc · CIK 1395937 · Engraved from SEC EDGAR